研究文章
Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial
Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4